IXALTIS

IXALTIS was created to develop and eventually market compounds alongside further products to be acquired through licensing/acquisition in the genitourinary sphere. The company’s objective is to extend its portfolio, in order to become a leading developer of innovative pharmaceutical products for treating disorders of the urogenital tract, bringing to the clinic solutions for diseases that affect many people and for which there are few or no satisfactory treatments.